Menu

Blog

Archive for the ‘neuroscience’ category: Page 769

May 13, 2019

Detecting dementia’s damaging effects before it’s too late

Posted by in categories: biotech/medical, health, neuroscience

Scientists might have found an early detection method for some forms of dementia, according to new research by the University of Arizona and the University of Toronto’s Baycrest Health Sciences Centre.

According to the study published in the journal Neuropsychologia last month, patients with a rare neurodegenerative disorder called Primary Progressive Aphasia, or PPA, show abnormalities in in areas that look structurally normal on an MRI scan.

“We wanted to study how degeneration affects function of the brain,” said Aneta Kielar, the study’s lead author and assistant professor in the UA Department of Speech, Language and Hearing Sciences.

Continue reading “Detecting dementia’s damaging effects before it’s too late” »

May 13, 2019

Awakening stem cells to unlock the brain’s regenerative potential

Posted by in categories: biotech/medical, chemistry, neuroscience

The human body has powerful healing abilities. But treating brain disorders is no easy task, as brain cells—neurons—have limited ability to regenerate. Nonetheless, stem cells are a form of natural backup, a vestige of our days as still-developing embryos.

The difficulty is that with age, neural stem cells ‘fall asleep’ and become harder to wake up when repairs are needed. Despite efforts to harness these cells to treat neurological damage, scientists have until recently been unsuccessful in decoding the underlying ‘sleep’ mechanism.

Now, researchers at Kyoto University studying brain chemistry in mice have revealed the ebb and flow of gene expression that may wake neural stem cells from their slumber. These findings, which may also apply to stem cells elsewhere in the body, were recently published in the journal Genes & Development.

Continue reading “Awakening stem cells to unlock the brain’s regenerative potential” »

May 12, 2019

The Entropic Enigma of Ouroboros’ Metamorphosis

Posted by in categories: energy, neuroscience

Antonin Tuynman: Where we see complexity, we see high informational content, organised in a complex way which often involves hierarchical levels. The diversity in highly complex systems might at first glance seem a chaotic mixed bag and hodgepodge; it is not. The diversified apparent mishmash is not a sign of apparent chaos, where you’d expect high thermodynamic entropy. It is not the stifling rigidity of a perfect order either. Complexity is an intricate architecture of stacked and intertwined hierarchical levels, with multifarious information exchanges between them. In fact Complexity selects the best of Order and Chaos. This seemingly ordered chaos or chaotic order, brings us the gift of the ability to ever introduce new variations. An ability to regenerate, copy, multiply and spread itself. An ability to induce ever changing patterns to adapt itself to the circumstances. An ability of recursive self-modification. Also knowhttps://www.ecstadelic.net/top-stories/the-entropic-enigma-o…amorphosis #OuroborosCode


The mighty worm Ouroboros had lost trace of its path and didn’t know its whereabouts. Nor did it know where it was going. In fact it didn’t know anything anymore, as it had drunk from the Lethe, Hades’ river flowing though Hypnos’ caves. Drinking from Lethe, forgetfulness and daughter of Eris, Goddess of Strife and Discord, made one lose all memory of past existence.

Disoriented Ouroboros started turning, and by continuing to turn, it finally found a trail of what seemed to be a path. A tasty object lay there, waiting to be eaten, and as Ouroboros bit it, a painful jolt of energy shot through its body awakening all the memories it had forgotten. Abruptly Ouroboros awoke from its dreamtime of daze and stupor and recognized itself as the ever effulgent Consciousness, Creator of Macrocosm and Microcosm.

Continue reading “The Entropic Enigma of Ouroboros’ Metamorphosis” »

May 11, 2019

New Treatment May Have the Potential to Slow, Stop, or Reverse Parkinson Disease

Posted by in categories: biotech/medical, neuroscience

Results from a recent study suggest that a revolutionary treatment may have the potential to slow, stop, or even reverse the progression of Parkinson disease.

Results from a February study of a revolutionary treatment suggest that it may be possible to slow, stop, or even reverse the progression of Parkinson disease, according to findings in the Journal of Parkinson’s Disease.

The 3-part, experimental study investigated whether using a novel delivery system to increase levels of glial cell line-derived neurotrophic factor (GDNF) can regenerate dying dopamine brain cells in patients with Parkinson disease and even reverse their condition. GDNF is a naturally occurring protein that promotes the survival of many types of neurons.

Continue reading “New Treatment May Have the Potential to Slow, Stop, or Reverse Parkinson Disease” »

May 11, 2019

Neuroscientist Dr Hannah Critchlow: ‘Changing the way that you think is cognitively costly’

Posted by in categories: biotech/medical, food, neuroscience

The concept of fate is often used in the context of love and choosing a partner. In your book, you talk about a study that give a scientific explanation for the idea that “opposites attract”. A panel of men was asked to wear a T-shirt for several nights and days and they weren’t allowed to wear deodorant or eat anything too smelly. The T-shirts were presented to an array of women who were asked to sniff then and rate them in terms of attractiveness based purely on smell. It turns out that the females rated the males as more attractive if their MHC [major histocompatibility complex] systems were different from their own, because then their offspring would have a stronger immune system, a better range of armoury against potential infections. So women were kind of sniffing out Mr Right.

What else does neuroscience tell us about a successful relationship? If you image the brains of the couples who have been together for a long, long time and ask them to think about their partner, their brain will react in the same way as a drug addict’s. You can almost say this couple are addicted to each other.

You say “affection is a neurochemical event” – that’s not very romantic. Valentine’s Day with me is a lot of fun!

Continue reading “Neuroscientist Dr Hannah Critchlow: ‘Changing the way that you think is cognitively costly’” »

May 10, 2019

How scorpion venom is helping surgeons detect brain cancer

Posted by in categories: biotech/medical, neuroscience

A new imaging technique designed to help surgeons identify the location of malignant brain tumors during surgery is showing promising early clinical trial results. The technique combines a new high-sensitivity near-infrared camera with a special imaging agent synthesized from an amino acid found in scorpion venom.

Read more

May 10, 2019

Brain Computer Interface Market — Bridging Gaps Between Machines And Humans

Posted by in categories: computing, habitats, neuroscience, virtual reality

A rise in the number of game developers, adoption of brain computer technology to enhance the complete gaming experience is triggering the growth of BCI market. The BCI application in 2017 has also influenced the smart home control sector and is believed to grow rapidly during the forecast period of 2018 to 2025. The high living standards across U.S and Canada are held responsible for the demand of BCI in smart home control system industry.

Brain-computer interface (BCI) is a technology that agree to communicate between a human-brain with an external technology. The term can be referred to an interface that takes signals from the brain to an external piece of hardware that sends signals to the brain. There are different brain-computer interface technologies developed, through different methods and for diversified purposes, including in virtual reality technology.

Get sample copy of this study

Continue reading “Brain Computer Interface Market — Bridging Gaps Between Machines And Humans” »

May 10, 2019

Statins may hold key to stopping multiple sclerosis, say UCL scientists

Posted by in categories: biotech/medical, neuroscience

Statins may hold the answer to slowing the deterioration of patients with multiple sclerosis (MS), scientists have said.

In a new trial hailed as “highly promising”, patients who took the daily pill retained their coordination better and suffered less brain shrinkage than those given a placebo.

It raises the prospect that MS sufferers, of whom there are more than 90,000 in the UK, may be prescribed the common cholesterol-busting drug to improve their symptoms.

Continue reading “Statins may hold key to stopping multiple sclerosis, say UCL scientists” »

May 9, 2019

In China, Surgeons Are Treating Addiction With Brain Implants

Posted by in categories: biotech/medical, neuroscience

Deep brain stimulation (DBS), an experimental technology that involves implanting a pacemaker-like device in a patient’s brain to send electrical impulses, is a hotly debated subject in the field of medicine. It’s an inherently risky procedure and the exact effects on the human brain aren’t yet fully understood.

But some practitioners believe it could be a way to alleviate the symptoms of depression or even help treat Alzheimer’s — and now they suspect it could help with drug addiction as well.

In a world’s first, according to the Associated Press, a patient in Shanghai’s Ruijin Hospital had a DBS device implanted in his brain to treat his addiction to methamphetamine.

Continue reading “In China, Surgeons Are Treating Addiction With Brain Implants” »

May 9, 2019

Risperidone-Associated Neuroleptic Malignant Syndrome in an Inpatient With Schizophrenia, With Successful Rechallenge and 3 Year Follow-Up

Posted by in categories: biotech/medical, food, neuroscience

Neuroleptic malignant syndrome (NMS) is rare but one of the most serious adverse effects of antipsychotics. Here, we report a case of risperidone-associated NMS in which a successful rechallenge of risperidone was observed with a positive follow-up. A 47-year-old female with schizophrenia was treated with risperidone 4 mg/d for 8 months in 2009 and was admitted to our hospital in 2015 owing to violent behavior under persecutory delusions. Risperidone 2 mg/d was initiated and increased to 4 mg/d 54 days later. Further, long-acting injectable (LAI) risperidone 25 mg per 2 weeks was added on hospital day 15. On hospital day 116, NMS occurred and thus we discontinued all antipsychotics including LAI risperidone, then NMS improved. We resumed LAI risperidone 25 mg per 2 weeks on hospital day 148, thus we waited for 22 days before re-starting the drug treatment. She was discharged on hospital day 371, then switched to LAI paliperidone 150 mg per 4 weeks 2 months later. At the time of a follow-up 3 years later, NMS had not reoccurred. This case reports on an unusual presentation of NMS in which no hyperthermia was observed. Furthermore, this case indicated that NMS may occur in a dose-dependent manner. In conclusion, this case reported important information for clinicians with regard to antipsychotic drug rechallenges and proper dosing of APs to avoid or reverse NMS.

A 47-year-old female with schizophrenia and without other neuropsychiatric or systemic illnesses was treated with risperidone 4 mg/d for 8 months in 2009. In 2015, she was admitted owing to the violent behavior of attacking her mother-in-law under persecutory delusion with the belief that her mother-in-law was going to murder her and auditory hallucination of hearing her mother-in-law criticize her behind her back. Risperidone 2 mg/d was initiated and increased to 4 mg/d 54 days later. Further, long-acting injectable (LAI) risperidone 25 mg per 2 weeks was added on hospital day 15. She did not receive any mood stabilizers on admission, such as lithium, carbamazepine, valproate. During treatment, the patient complained of soreness and weakness of her whole body, and refused to eat or ambulate on hospital day 116, at which point she was tachycardic with a bpm of 116, but afebrile (36.4°C) with stable blood pressure (113÷72 mm Hg).

Read more

Page 769 of 1,027First766767768769770771772773Last